| Hans-Günter Meyer-Thompson | Naltrexon
Adapting treatment length to opioid‐dependent individuals’ needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone.
Adapting treatment length to opioid‐dependent individuals’ needs and preferences: a 2‐year follow‐up to a 1‐year study of extended‐release naltrexone.
Solli, K. K., Opheim, A., Latif, Z., Krajci, P., Benth, Jė. Š., Kunoe, N., and Tanum, L. (2021)
Addiction, doi.org/10.1111/add.15378.